Released Nov 14, 2011, during market hours
10-Q filed Nov 14, 2011, 45 days after period end · 0000950123-11-098294
Q3 2011 · 10-Q
Revenue—
Net Income-$5.48M-$5.48M N/M vs Q3 2010N/M vs Q2 2011
EPS Diluted-$0.14-$0.14 N/M vs Q3 2010N/M vs Q2 2011
Operating Cash Flowderived-$3,413,000N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$5.48M | -$4.14M |
| EPS Diluted | -$0.14 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR